About Cocoon Biotech

Cocoon Biotech’s platform technology is a biocompatible silk protein that can be injected into joints to provide effective long lasting pain relief and potentially delay the progression of disease. This platform will leverage several unique properties of the silk protein fibroin, including strength, lubrication, and biocompatibility. Their mission is to use this technology to significantly improve the treatment of osteoarthritis and other degenerative joint disorders. The osteoarthritis treatmen

Company Highlights
Year Founded

2013

icon-altEmployees

6

Location (HQ)

USA

Since Last Funding

2 years 9 months

Monthly Website Visitors

297

icon-altTotal Investment Amt

$5.7M

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Medical

Biotechnology

Biotechnology Research